Scoring system assessing mucosal visibility of upper gastrointestinal tract: The POLPREP scale
- PMID: 34397116
- DOI: 10.1111/jgh.15662
Scoring system assessing mucosal visibility of upper gastrointestinal tract: The POLPREP scale
Abstract
Background and aim: The proper visibility of mucosa during esophagogastroduodenoscopy (EGD) is crucial for the detection of early upper gastrointestinal tract lesions. In contrast to colonoscopy, no validated scoring system for the assessment of upper gastrointestinal mucosal cleanliness has been developed so far. The aim of the study was to create and validate standardized grading system (POLPREP) to assess the mucosal cleanliness during EGD.
Methods: To assess the visibility of mucosa during EGD, 4-point scale was developed (0-3). Twelve operators assessed 18 images of esophagus, stomach, and duodenum twice (in 2 weeks interval). In validation round, the images and endoscopy reports of 443 EGDs performed in six centers were assessed.
Results: The inter-observer accordance of POLPREP was 0.8 (intra-class correlation coefficient; 0.79 consultants, 0.85 trainees). The intra-observer repeatability was 0.64 (Fleiss kappa value; 0.64 consultants, 0.64 trainees). The lesions detection rate was significantly higher in clean (scores 2 and 3; 19.7%) than in "unclean" segments (score 1; 7.7%, P = 0.049). Score 3 was associated with over three-fold higher lesion detection than score 1 (odds ratio 3.2, 95% confidence interval 1.1-9; P = 0.03).
Conclusions: The proposed POLPREP scale allows for unified assessment of upper gastrointestinal tract mucosal cleanliness. The higher cleanliness scores are related with greater upper gastrointestinal pathologies detection.
Keywords: Esophagogastroduodenoscopy; Preparation; Upper gastrointestinal tract; Visualization.
© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021; 71: 209-249. https://doi.org/10.3322/caac.21660
-
- Peery AF, Crockett SD, Murphy CC et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2020; 156: 254-272.
-
- Bhandari P, Green S, Hamanaka H et al. Use of gascon and pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial. Scand. J. Gastroenterol. 2010; 45: 357-361.
-
- Wu L, Cao Y, Liao C, Huang J, Gao F. Systematic review and meta-analysis of randomized controlled trials of Simethicone for gastrointestinal endoscopic visibility. Scand. J. Gastroenterol. 2011; 46: 227-235.
-
- Chang CC, Chen SH, Lin CP et al. Premedication with pronase of N-acetylcysteine improves visibility during gastroendoscopy: An endoscopist-blinded, prospective, randomized study. World J. Gastroenterol. 2007; 13: 444-447.
MeSH terms
LinkOut - more resources
Full Text Sources
